Investment House LLC’s Sonnet BioTherapeutics SONN Stock Holding History

Investment House LLC’s Portfolio SONN Stock Details SONN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,625	Closed	-$48.7K	–	231
2025 Q3	$48.7K	Buy	+10,625	New	+$47.1K	﹤0.01%	222

Other funds holding SONN

FAM

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

Investment House LLC's SONN Position: Q4 2025 in Review

Investment House LLC sold out of Sonnet BioTherapeutics (SONN) in Q4 2025, closing a stake of 10,625 shares — an estimated $48.7K sold.

Investment House LLC first reported a position in SONN in Q3 2025 and held it in 1 quarter. The position peaked at $48.7K in Q3 2025. 1 fund tracked by Wall St. Rank holds SONN as of Q4 2025.

Investment House LLC reported no remaining Sonnet BioTherapeutics position as of Q4 2025 after selling out during the quarter.
Investment House LLC sold 10,625 Sonnet BioTherapeutics shares in Q4 2025, an estimated $48.7K.
Investment House LLC first reported a position in Sonnet BioTherapeutics in Q3 2025 and held it in 1 quarter.
Investment House LLC's Sonnet BioTherapeutics position peaked at $48.7K in Q3 2025.
1 fund tracked by Wall St. Rank held Sonnet BioTherapeutics as of Q4 2025.

Based on Investment House LLC's 13F filing for Q4 2025, filed 6 Feb 2026.